Skip to main content
SpringerLink
Log in

Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: A comparison with aspirin and naproxen

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The effect of treatment with the new anti-inflammatory drug etodolac on the articular and bone pathology associated with adjuvant arthritis in rats has been compared to the effects produced by aspirin and naproxen. Five measures of drug effect were made (changes in hind paw edema, body weight, normal hind leg function and articular damage as assessed by radiologic and histopathologic techniques). Drug treatment was initiated 16 days after adjuvant injection when arthritis was already established and continued for either 14 or 28 days. Etodolac produced a dose-related inhibition of all arthritic changes. Results from the radiologic study indicated that etodolac not only prevented the further development of articular damage by arthritis but actually caused a regression of these lesions established before drug treatment began. Similar results were obtained from the histopathologic study. Naproxen prevented the further development of arthritic damage but aspirin, although it decreased hind paw edema and increased body weight gains, had no significant effect on the articular damage produced by arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. Vetter, M. Placchi, andL. Joubert,Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients. Int. J. clin. Pharmac. Toxicol.20, 240–245 (1982).

    Google Scholar 

  2. L. Verischelen, P. Bilsback, G. Rolly, M. Merlo andL. Joubert,Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo. Int. J. clin. Pharmac. Toxicol.20; 236–239 (1982).

    Google Scholar 

  3. L. Joubert, L.F. Mullane, M. Merlo, R. Martel, J. Arnold, G. Rolly andG. Vetter,Clinical pharmacological profile of Ultradol ®,a new nonsteroidal anti-inflammatory drug. Curr. ther. Res.32, 74–88 (1982).

    Google Scholar 

  4. R.R. Martel andJ. Klicius,Anti-inflammatory and analgesic properties of etodolic acid. Can. J. Physiol. Pharmac.54, 245–248 (1976).

    Google Scholar 

  5. J.M. Hall andC. Hallett,A simple precise method for measuring rodent paw volume. J. Pharm. Pharmac.27, 623 (1975).

    Google Scholar 

  6. S. Siegel,Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York (1956).

    Google Scholar 

  7. A.S. Watnick, The adjuvant arthritic rat: a tool for discovering antiarthritic drugs.Immunopharmacology, pp. 115–171 (EdsM.E. Rosenthale andM.C. Mansmann, Jr Spectrum Publications, Inc., New York 1975.

    Google Scholar 

  8. M.E. Rosenthale andR.J. Capetola,Adjuvant arthritis: immunopathological and hyperalgesic features. Fedn Proc.41, 2577–2582, 1982.

    Google Scholar 

  9. C.M. Pearson andF.D. Wood,Studies on polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. 1. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum.2, 440–459 (1959).

    Google Scholar 

  10. R.S. Jones andJ.R. Ward,Studies on adjuvant-induced polyarthritis in rats. 2. Histogenesis of joint and visceral lesions. Arthritis Rheum.6, 23–35, (1963).

    Google Scholar 

  11. S. Wong, Pharmacology of tolmetin: 1-Methyl-5-p-toluoylpyrrole-2-acetic acid. InTolmetin, a New Non Steroidal Anti-Inflammatory Agent. Excerpta med. 1–22 (1976).

  12. A. Blackham, J.W. Burns, J.B. Farmer, H. Radziwonik andJ. Westwick,An X-ray analysis of adjuvant arthritis in the rat: the effect of prednisolone and indomethacin. Agents and Actions7, 145–151 (1977).

    PubMed  Google Scholar 

  13. N.R. Ackerman, W.H. Rooks, II, L. Shott, H. Genant, P. Maloney andE. West,Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum.22, 1365–1374 (1979).

    PubMed  Google Scholar 

  14. I.G. Otterness, D.L. Larson andJ.G. Lombardino,An analysis of piroxicam in rodent models of arthritis. Agents and Actions12, 308–311 (1982).

    PubMed  Google Scholar 

  15. D.N. Benslay andR. Nickander,Comparative effects of benoxaprofen and other anti-inflammatory drugs on bone damage in the adjuvant arthritic rat. Agents and Actions12, 313–319 (1982).

    PubMed  Google Scholar 

  16. R.R. Martel andJ. Klicius,Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs. Agents and Actions12: 295–297 (1982).

    PubMed  Google Scholar 

  17. P.L. Boardman andF. Dudley Hart,Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br. med. J.4: 264–268 (1967).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Ayerst Laboratories, H4R 1J6, Montreal, Quebec, Canada

    R. R. Martel, J. Klicius & G. Metcalf

Authors
  1. R. R. Martel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Klicius
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Metcalf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martel, R.R., Klicius, J. & Metcalf, G. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: A comparison with aspirin and naproxen. Agents and Actions 14, 257–264 (1984). https://doi.org/10.1007/BF01966650

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966650

Keywords

Search

Navigation